Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Integrative Analysis of Single-Cell Transcriptomics and Mendelian Randomization Reveals BTN3A2 as a Common Protective Factor in Behçet’s Disease and Inflammatory Bowel Disease

  • By

  • Qinjin Dai

  • Yuelan Wu

  • Wenbo Geng

  • Mengna Li

  • Wanyun Zhang

  • Yuxian Lai

  • Pei Zhang

  • Chunjiang Zhou

  • Yinuo Wang

  • Qingfeng Cao

  • Xiang Luo

  • Yujie Lai

  • Changwei Huang

  • Peizeng Yang

  • June 24, 2026

Share

Original Source(s)

Integrative single-cell transcriptomics and mendelian randomization identifies BTN3A2 as a shared protective factor in Behçet’s disease and inflammatory bowel disease

  • by Qinjin Dai, Yuelan Wu, Wenbo Geng, Mengna Li, Wanyun Zhang, Yuxian Lai, Pei Zhang, Chunjiang Zhou, Yinuo Wang, Qingfeng Cao, Xiang Luo, Yujie Lai, Changwei Huang, Peizeng Yang

  • June 24, 2026

Related Content

Longitudinal Performance of the Psoriasis Epidemiology Screening Tool (PEST) in Canada and Latin America: Results from the Prospective, Observational, 5-Year PURE Registry

Correction: Electroacupuncture delays the progression of juvenile collagen-induced arthritis via regulation NLRP3/NF-κB signaling pathway -mediated pyroptosis and its influence on autophagy

Systematic analysis of adverse reaction signals induced by leflunomide, upadacitinib, and baricitinib in the treatment of rheumatoid arthritis: a FAERS database analysis